The Top Five Guru-Held Mid-Cap Stocks of Q2

Using the GuruFocus Aggregated Portfolio Screener you can filter results to see what companies maintain the highest amount of guru ownership. By using this screener, we filtered down to see mid-cap companies which are held by the most gurus. The following five mid-capped companies are held by the largest number of gurus during the past quarter.


Quest Diagnostics (DGX)

As of the close of the second quarter there were 19 guru owners of Quest Diagnostics. During the past quarter there were six gurus buying shares of DGX and there were twelve gurus making sells of their stake in the company. These gurus maintain a combined weighting of 5.76%.

Top three guru shareholders of Quest Diagnostics:

1. Chris Davis (Trades, Portfolio): 4,672,681 shares, representing 3.23% of the company's shares outstanding and 0.82% of the fund's total portfolio.

2. Brian Rogers (Trades, Portfolio): 3,000,000 shares, representing 2.08% of the company's shares outstanding and 0.62% of his total portfolio

3. HOTCHKIS & WILEY: 2,523,400 shares, representing 1.75% of the company's shares outstanding and 0.52% of his total portfolio.

Quest Diagnostics and its subsidiaries are the providers of diagnostic testing, information and services, providing insights that enable patients and physicians to make better healthcare decisions.

Quest Diagnostics' historical revenue and net income:

1409849879551.png
1409849879551.png



The analysis on Quest reports that the company has shown predictable revenue and earnings growth, its operating margin is expanding and its price is near a 10-year high.

The Peter Lynch Chart suggests that the company is currently undervalued:

1409850103223.png
1409850103223.png



Quest Diagnostics has a market cap of $9.14 billion. Its shares were trading at around $63.28 with a P/E ratio of 12.20, a P/S ratio of 1.30 and a P/B ratio of 2.10. The company had an annual average earnings growth of 8.50% over the past ten years.

GuruFocus rated Quest Diagnostics the business predictability rank of 4-star.

Laboratory Corp of America Holdings (LH)

As of the close of the second quarter there were 18 guru owners of Laboratory Corp of America. During the past quarter there were eight gurus buying shares of LH and there were nine gurus making sells of their stake in the company. These gurus maintain a combined weighting of 12.1%.

Top three guru shareholders of Laboratory Corp of America:

1. Chris Davis (Trades, Portfolio): 6,747,256 shares, representing 7.96% of the company's shares outstanding and 2.1% of the fund's total portfolio.

2. Richard Pzena (Trades, Portfolio): 1,654,529 shares, representing 1.95% of the company's shares outstanding and 0.94% of his total portfolio

3. John Rogers (Trades, Portfolio): 1,087,739 shares, representing 1.28% of the company's shares outstanding and 1.4% of his total portfolio.

Through its national network of laboratories, Laboratory Corp of America offers a broad range of clinical laboratory tests that are used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease. In addition, the company has developed testing operations, such as oncology testing, HIV genotyping and phenotyping, diagnostic genetics and clinical trials.

Laboratory Corp of America's historical revenue and net income: